KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Astrazeneca (AZN) Operating Margin (2016 - 2025)

Historic Operating Margin for Astrazeneca (AZN) over the last 16 years, with Q4 2025 value amounting to 19.21%.

  • Astrazeneca's Operating Margin rose 55400.0% to 19.21% in Q4 2025 from the same period last year, while for Dec 2025 it was 23.4%, marking a year-over-year increase of 49000.0%. This contributed to the annual value of 23.4% for FY2025, which is 49000.0% up from last year.
  • According to the latest figures from Q4 2025, Astrazeneca's Operating Margin is 19.21%, which was up 55400.0% from 23.59% recorded in Q3 2025.
  • Astrazeneca's Operating Margin's 5-year high stood at 699.44% during Q3 2022, with a 5-year trough of 16.97% in Q3 2021.
  • For the 5-year period, Astrazeneca's Operating Margin averaged around 99.93%, with its median value being 21.37% (2023).
  • In the last 5 years, Astrazeneca's Operating Margin surged by 7164100bps in 2022 and then tumbled by -6824400bps in 2023.
  • Over the past 5 years, Astrazeneca's Operating Margin (Quarter) stood at 2.43% in 2021, then soared by 28581bps to 692.41% in 2022, then tumbled by -99bps to 10.26% in 2023, then soared by 33bps to 13.67% in 2024, then soared by 40bps to 19.21% in 2025.
  • Its Operating Margin stands at 19.21% for Q4 2025, versus 23.59% for Q3 2025 and 24.27% for Q2 2025.